Abiopharma

(99% Neutral) CANTOR EQUITY PARTNERS VI, INC. (CEPS) Announces New Board Appointment

(30% Negative) PENNYMAC FINANCIAL SERVICES, INC. (PFSI) Reports Q2 2026 Financial Results

📋 RAMAN CHITKARA (Director) plans to sell 5K shares of Arteris, Inc. (at $28.85 each, total $144K) Filed: May 05, 2026 | ID: 004056

Balcom Alexandra 🟡 adjusted position in 11.4K shares (2 derivative) of Nuvalent, Inc. (NUVL) at $99.97 ($1.2M) Transaction Date: May 01, 2026 | Filing ID: 000005

EDGEMOND JAMES 🟡 adjusted position in 10.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $582.29 ($8.5M) Transaction Date: May 04, 2026 | Filing ID: 000015

Director KLEIN JOSEPH III 🟡 adjusted position in 10.1K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $74.45 ($1.7M) Transaction Date: May 01, 2026 | Filing ID: 000182

(99% Neutral) FULTON FINANCIAL CORP (FULTP) Announces Update on Collaboration with Registrant

(30% Negative) HERCULES CAPITAL, INC. (HCXY) Reports Q2 2026 Financial Results

(99% Neutral) MAYVILLE ENGINEERING COMPANY, INC. (MEC) Reports Q2 2026 Financial Results

(99% Neutral) UNITIL CORP (UTL) Announces Business Combination